Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US0028241000
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000B9ZXB4
ABT
Abbott Laboratories
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Medical Devices · THEMEFOLIO: $HLTH
NAME
Abbott Laboratories
ISIN
US0028241000
TICKER
ABT
MIC
XNYS
REUTERS
ABT.N
BLOOMBERG
ABT US
Do., 26.06.2025       Abbott Labs
US0028241000

ABBOTT PARK, Ill., June 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2025 financial results on Thursday, July 17, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Re...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Sa., 21.06.2025       Abbott Labs
US0028241000

Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows people participating in Abbott's Healthy Food Rx ate more vegetables and fruit, and reported significantly improved health status.Abbott's Healthy Food Rx community-focused "food is medicine" program provides home-delivered healthy food bo...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 16.06.2025       Abbott Labs
US0028241000

The test, run on Abbott's portable i-STAT® Alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), otherwise known as concussionThe test produces lab-quality results in 15 minutesClinicians can get a result at the patient's bedside, making the test accessible at urgent care clinics and...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Fr., 13.06.2025       Abbott Labs
US0028241000

ABBOTT PARK, Ill., June 13, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share. This marks the 406th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2025, to shareholders of record at the close of business on July...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Di., 27.05.2025       Abbott Labs
US0028241000

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC)Tendyne offers a new treatment option for patients who are not candidates for open-heart surgery or mitral repairThis approval expands Abbott's portfolio of minimally...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 15.05.2025       Abbott Labs
US0028241000

New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors.1Results also show a reduction in hospitalization for ca...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 07.05.2025       Abbott Labs
US0028241000

This summer, Abbott and Real Madrid are hosting tryouts across the U.S. to form the 'Abbott Dream Team'Tryout attendees will learn about health and sports nutrition, encouraging them to promote healthy habits and an active lifestyle in their communitiesEleven selected players will travel to Madrid, train at Real Madrid's world-class facilities, a...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 01.05.2025       Abbott Labs
US0028241000

The test, run on Abbott's portable i-STAT® Alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutesThe test will be used by healthcare professionals in the medical facilities at all MotoAmerica races...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Di., 29.04.2025       Abbott Labs
US0028241000

Collaboration brings together FreeStyle Libre® Systems, the world's leading continuous glucose monitoring technology (CGM)1 with Epic, a healthcare software company, to streamline access to CGM data for healthcare organizationsIntegration empowers U.S. clinicians to enhance patient care by incorporating Libre's data directly into their workflowsA...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
So., 27.04.2025       Abbott Labs
US0028241000

Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has also begun in the ASCEND CSP pivotal clinical trial to evaluate Abbott's investigational CSP Implantable Cardioverter-Defibrillator (ICD) lead Conductio...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Silent Ad
So., 27.04.2025       Abbott Labs
US0028241000

Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA SystemThe 12-month results of the Volt CE Mark Study confirm the long-term safety and efficacy of the Volt PFA SystemThe data were presented at the 2025 Heart Rhythm Society (HRS) annual meet...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
So., 27.04.2025       Abbott Labs
US0028241000

Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA SystemThe 12-month results of the Volt CE Mark Study confirm the long-term safety and efficacy of the Volt PFA SystemThe data were presented at the 2025 Heart Rhythm Society (HRS) annual meet...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 16.04.2025       Abbott Labs
US0028241000

First-quarter GAAP diluted EPS of $0.76; adjusted diluted EPS of $1.09First-quarter reported sales growth of 4.0 percent; organic sales growth of 6.9 percent or 8.3 percent when excluding COVID-19 testing-related sales1Reported gross margin of 52.8 percent of sales; adjusted gross margin of 57.1 percent, which reflects a 140 basis point increaseR...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 14.04.2025       Abbott Labs
US0028241000

Das Instrument ABL US0028241000 ABBOTT LABS EQUITY wird ex Dividende/Zinsen gehandelt am 15.04.2025 The instrument ABL US0028241000 ABBOTT LABS EQUITY has its ex-dividend/interest day on 15.04.2025...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 31.03.2025       Abbott Labs
US0028241000

TRILUMINATE™ Pivotal data presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in Circulation show the Abbott TriClip system reduces heart failure hospitalizationsThe latest results highlight significant improvements in tricuspid regurgitation and quality of life through two yearsABBOTT...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 27.03.2025       Abbott Labs
US0028241000

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation – or PFA – uses high energy electrical pulses for ablation procedures that may offer benefits to targeting and treating tissue in the heartAbbott's Volt PFA System is designed to overcom...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 27.03.2025       Abbott Labs
US0028241000

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation – or PFA – uses high energy electrical pulses for ablation procedures that may offer benefits to targeting and treating tissue in the heartAbbott's Volt PFA System is designed to overcom...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 26.03.2025       Abbott Labs
US0028241000

ABBOTT PARK, Ill., March 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2025 financial results on Wednesday, April 16, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 24.03.2025       Abbott Labs
US0028241000

Coronary Artery Disease (CAD) is the most common heart disease and most frequent cause of death in the U.S., with over 20 million adults affected by this conditionAbbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockagesAbbott offers...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Fr., 21.02.2025       Abbott Labs
US0028241000

ABBOTT PARK, Ill., Feb. 21, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share. This marks the 405th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2025, to shareholders of record at the close of business on April...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 04.02.2025       Abbott Labs
US0028241000

New survey shows 40% of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma170% of people with diabetes said supportive comments from others can significantly boost their motivation to manage their condition1Abbott launches film that highlights challenges of living life with diabetesABBOTT PARK, Ill.,...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Di., 04.02.2025       Abbott Labs
US0028241000

New survey shows 40 per cent of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma170 per cent of people living with diabetes said supportive comments from others can significantly boost their motivation to manage their condition1Abbott launches film that highlights challenges of living life with diab...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 22.01.2025       Abbott Labs
US0028241000

Fourth-quarter sales of $11.0 billion; full-year 2024 sales of $42.0 billionFourth-quarter reported sales increased 7.2 percent; organic sales growth for the underlying base business increased 10.1 percent1Full-year 2024 reported sales increased 4.6 percent; organic sales growth for the underlying base business increased 9.6 percent2Abbott projec...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 02.01.2025       Abbott Labs
US0028241000

ABBOTT PARK, Ill., Jan. 2, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2024 financial results on Wednesday, Jan. 22, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8:30 a.m. Central time (9:30 a.m. Eastern) and will be accessible through Abbott's Inves...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Di., 17.12.2024       Abbott Labs
US0028241000

MISSISSAUGA, ON, Dec. 17, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2* flash glucose monitoring system to the Alberta Drug Benefit List. Starting December 16, 2024, Alberta residents living with diabetes can access provincial reimbursement of the FreeStyle Libre 2 system if...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Di., 17.12.2024       Abbott Labs
US0028241000

Abbott's investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural conduction systemThe device has received U.S. Food and Drug Administration Breakthrough Device Designation, which expedites the review of innovative tech...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Fr., 13.12.2024       Abbott Labs
US0028241000

Dividend increased by 7.3%Quarterly dividend payout has increased more than 60% since 2020404th consecutive quarterly dividend to be paid by Abbott since 1924ABBOTT PARK, Ill., Dec. 13, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 59 cents per share, a...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
So., 08.12.2024       Abbott Labs
US0028241000

Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten nationwide competition this college football season, helping save as many as 60,000 livesNebraska's win was announced at the Discover Big Ten Football Championship Game where the university received $1 million from global healthcare comp...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 25.11.2024       Abbott Labs
US0028241000

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve diseaseThe investigational system is designed to offer best-in-class heart blood flow, ease of use and precisionApproximately 9% of older Americans have aortic steno...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 18.11.2024       Abbott Labs
US0028241000

An Taoiseach, Simon Harris, TD, und Robert Ford, Chairman und Chief Executive Officer von Abbott, nehmen an der offiziellen Eröffnung teilÜber 800 Mitarbeiter sollen in der Produktionsstätte für Diabetes-Technologie beschäftigt werden, die Teil einer 440-Millionen-Euro-Investition ist, die Abbott an zwei Standorten in Irland tätigt.Die Anlage wir...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 18.11.2024       Abbott Labs
US0028241000

An Taoiseach, Simon Harris, TD, and Abbott Chairman and Chief Executive Officer, Robert Ford, attend official openingOver 800 to be employed at the diabetes technology manufacturing site, which is part of a €440 million investment Abbott is making across two sites in IrelandFacility will have the highest production of FreeStyle Libre® sensors in...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 30.10.2024       Abbott Labs
US0028241000

Canadians living with type 2 diabetes agree that uplifting words, positive feedback and supportive tools are the most powerful motivatorsMISSISSAUGA, ON, Oct. 30, 2024 /CNW/ -- Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, revealing key motivators to help them manage...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 24.10.2024       Abbott Labs
US0028241000

The first-of-its-kind TEAM-HF study seeks to improve clinical outcomes in patients with worsening heart failureTrial establishes new, objective criteria to identify patients most at risk for developing end-stage heart failure and potentially offer life-saving therapeutic options sooner in their disease progressionABBOTT PARK, Ill., Oct. 24, 2024...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 16.10.2024       Abbott Labs
US0028241000

Sales of $10.6 billion driven by strong underlying base business performance Reported sales growth of 4.9 percent; organic sales growth for underlying base business of 8.2 percent1, led by double-digit growth in Medical DevicesContinues to strengthen portfolio with steady cadence of new product approvals, reimbursement coverage, and clinical data...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 14.10.2024       Abbott Labs
US0028241000

Das Instrument ABL US0028241000 ABBOTT LABS EQUITY wird ex Dividende/Zinsen gehandelt am 15.10.2024 The instrument ABL US0028241000 ABBOTT LABS EQUITY has its ex-dividend/interest day on 15.10.2024...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
So., 13.10.2024       Abbott Labs
US0028241000

Das Instrument ABL US0028241000 ABBOTT LABS EQUITY wird cum Dividende/Zinsen gehandelt am 14.10.2024 und ex Dividende/Zinsen am 15.10.2024 The instrument ABL US0028241000 ABBOTT LABS EQUITY has its pre-dividend/interest day on 14.10.2024 and its ex-dividend/interest day on 15.10.2024...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 10.10.2024       Abbott Labs
US0028241000

Enrollment completed ahead of schedule in the global IDE for Abbott's Volt™ PFA SystemGlobal FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™, receives U.S. Food and Drug Administration clearance, begins commercial launchABBOTT PARK, Ill., Oct. 10, 2024...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 26.09.2024       Abbott Labs
US0028241000

To help address the greatest need for blood in a generation, Abbott, a global leader in blood testing, and the Big Ten Conference are teaming up to host the first college conference-wide blood donation competitionThe school that drives the most blood donations during the 2024 football season will be honored by Abbott at the Discover Big Ten Footb...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 25.09.2024       Abbott Labs
US0028241000

ABBOTT PARK, Ill., Sept. 25, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2024 financial results on Wednesday, Oct. 16, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor R...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 19.09.2024       Abbott Labs
US0028241000

ABBOTT PARK, Ill., Sept. 19, 2024 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share. This marks the 403rd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2024, to shareholders of record at the close of business on Oct...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 05.09.2024       Abbott Labs
US0028241000

Designed for people interested in improving their overall health and wellnessProvides real-time glucose data and personal coaching insights based on the body's reaction to nutrition, exercise and life's daily stressorsAvailable without a prescription; explore different purchase options at www.hellolingo.com  ABBOTT PARK, Ill., Sept. 5, 2024 /PRNe...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mi., 04.09.2024       Abbott Labs
US0028241000

The U.S. FDA granted Abbott Breakthrough Device designation to explore deep brain stimulation (DBS) for treatment-resistant depression (TRD) as an option to improve the lives of people with this debilitating conditionApproximately 2.8 million Americans each year are diagnosed with TRD, a form of major depressive disorder that has not responded to...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Di., 27.08.2024       Abbott Labs
US0028241000

Pure Bliss™ Organic and Pure Bliss Organic with A2 Milk infant formulas – both USDA-certified – are now part of the Pure Bliss by Similac® line that includes European-made Pure Bliss Irish Farms, which starts with fresh milk from cows in IrelandPure Bliss Organic in the 2-fluid ounce ready-to-feed bottle is the only USDA-certified organic liquid...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 15.08.2024       Abbott Labs
US0028241000

Abbott's AVEIR™ DR leadless pacemaker system was first implanted at the Montreal Heart Institute in Montreal, Quebec and Foothills Medical Centre in Calgary, AlbertaThe AVEIR DR leadless pacemaker system is designed to address abnormal heart rhythms 1Abbott's first-of-its-kind i2i™ technology enables synchronized communication between two leadles...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 08.08.2024       Abbott Labs
US0028241000

MISSISSAUGA, ON, Aug. 8, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Quebec's Régie de l'assurance maladie du Québec (RAMQ) published an update to its formulary that includes expanded reimbursement for Abbott's FreeStyle Libre 2* flash glucose monitoring system to more adults living with type 1 and type 2 diabetes.  A...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 18.07.2024       Abbott Labs
US0028241000

Sales of $10.4 billion driven by strong underlying base business performance Reported sales growth of 4.0 percent; organic sales growth for underlying base business of 9.3 percent1, led by double-digit growth in Medical DevicesContinues to strengthen portfolio with new product approvalsABBOTT PARK, Ill., July 18, 2024 /PRNewswire/ -- Abbott (NYSE...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Do., 11.07.2024       Abbott Labs
US0028241000

Das Instrument ABL US0028241000 ABBOTT LABS EQUITY wird cum Dividende/Zinsen gehandelt am 12.07.2024 und ex Dividende/Zinsen am 15.07.2024 The instrument ABL US0028241000 ABBOTT LABS EQUITY has its pre-dividend/interest day on 12.07.2024 and its ex-dividend/interest day on 15.07.2024...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Di., 29.11.2022       Abbott Labs
US0028241000

San Diego, California--(Newsfile Corp. - November 29, 2022) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Abbott Laboratories (NYSE: ABT).Investors who purchased Abbott Laboratories (NYSE: ABT) shares prior to February 2021 and continue to hold any of their NYSE: ABT shares have also cert...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
Mo., 31.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 31, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink
So., 30.10.2022       Abbott Labs
US0028241000

New York, New York--(Newsfile Corp. - October 30, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District Court for the Northern District of Illinois. This la...
Zur Nachricht
Abbott Labs
Charts & Research Termsheets Terminal
Permalink